Additionally, this study revealed that both diacylglycerol acyltransferase-1 (DGAT1) and ABHD5 are upregulated in prostate cancer cells, suggesting that inhibiting these two proteins could be novel anticancer approaches. This evidence concerns the gene ABHD5 and prostate cancer.